StockMarketWire.com - Regenerative medicine developer Collagen Solutions said its subsidiaries in the US and New Zealand had received a mix of loan and grant funding based on those governments' Covid-19 economic support programmes.

The US business received $240,000 in US government-backed loan funding through one of the company's banking providers.

Collagen Solutions NZ also received $NZ35k from the New Zealand Ministry for Social Development's Wage Subsidy Scheme.

'The company continues to pursue additional potential non-dilutive sources of cash including various governments' Covid-19 loans and grants,' Collagen Solutions said.


At 1:42pm: [LON:COS] Collagen Solutions Plc share price was +0.25p at 3.15p



Story provided by StockMarketWire.com